Immunohistochemistry (IHC) of clinical samples revealed that YTHDF2 expression increases with tumor grade and correlates positively with PRMT6 expression (Supplementary Material 4: Fig. S4I-K). The gene discussed is YTHDF2; the disease is neoplasm.